Clinical Trials · NCT00543218
PTH Comparison in Post Menopausal Women
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 63
- Start date
- Dec 2002
- Locations
- 4 sites, Taiwan
- Primary endpoint
- To compare in postmenopausal women with established osteoporosis the effect of treatment with teriparatide 20 micrograms/day subcutaneous with the effect of salmon calcitonin 100 IU/day subcutaneous on change in lumbar spine BMD.